Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort
- 8 April 2005
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 19 (6), 593-601
- https://doi.org/10.1097/01.aids.0000163936.99401.fe
Abstract
Whether hepatitis B (HBV) coinfection affects outcome in HIV-1-infected patients remains unclear. To assess the prevalence of HBV (assessed as HBsAg) coinfection and its possible impact on progression to AIDS, all-cause deaths, liver-related deaths and response to highly active antiretroviral therapy (HAART) in the EuroSIDA cohort. Data on 9802 patients in 72 European HIV centres were analysed. Incidence rates of AIDS, global mortality and liver-related mortality, time to 25% CD4 cell count increase and time to viral load HBsAg was found in 498 (8.7%) patients. The incidence of new AIDS diagnosis was similar in HBsAg-positive and HBsAg-negative patients (3.3 and 3.4/100 person-years, respectively) even after adjustment for potential confounders: the incidence rate ratio (IRR) was 0.94 [95% confidence interval (CI), 0.74–1.19; P = 0.61]. The incidences of all-cause and liver-related mortalities were significantly higher in HBsAg-positive subjects (3.7 and 0.7/100 person-years, respectively) compared with HBsAg-negative subjects (2.6 and 0.2/100 person-years, respectively). The adjusted IRR values were 1.53 for global (95% CI, 1.23–1.90; P = 0.0001) and 3.58 for liver-related (95% CI, 2.09–6.16; P The prevalence of HBV coinfection was 9% in the EuroSIDA cohort. Chronic HBV infection significantly increased liver-related mortality in HIV-1-infected patients but did not impact on progression to AIDS or on viral and immunological responses to HAART.Keywords
This publication has 25 references indexed in Scilit:
- Prevalence of Chronic Hepatitis B and Incidence of Acute Hepatitis B Infection in Human Immunodeficiency Virus–Infected SubjectsThe Journal of Infectious Diseases, 2003
- HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)The Lancet, 2002
- Dual Efficacy of Lamivudine Treatment in Human Immunodeficiency Virus/Hepatitis B Virus–Coinfected Persons in a Randomized, Controlled Study (CAESAR)The Journal of Infectious Diseases, 1999
- Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual menHepatology, 1999
- Hepatitis B and C in HIV-infected patientsJournal of Hepatology, 1997
- Interactions between HIV and hepatitis B virus in homosexual menAIDS, 1997
- Case-control study of sexually transmitted diseases as cofactors for HIV-1 transmissionInternational Journal of STD & AIDS, 1996
- Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDSAIDS, 1992
- Effect of duration of hepatitis B virus infection on the association between human immunodeficiency virus type-1 and hepatitis B viral replicationHepatology, 1992
- The Effect of Concurrent Human Immunodeficiency Virus Infection on Chronic Hepatitis B: A Study of 150 Homosexual MenThe Journal of Infectious Diseases, 1989